Evidence map›Paper›PMID 34193412›Full record

ArticleScience advances2021

Lacrimal gland budding requires PI3K-dependent suppression of EGF signaling.

Qian Wang, Chenqi Tao, Abdul Hannan, Sungtae Yoon, Xuanyu Min, John Peregrin, Xiuxia Qu, Hongge Li, Honglian Yu, Jean Zhao and 1 more

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. International journal of molecular sciences · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Qian WangDepartments of Ophthalmology, Pathology, and Cell Biology, Columbia University, New York, NY, USA.ORCID http://orcid.org/0000-0002-6166-3081
Chenqi TaoDepartments of Ophthalmology, Pathology, and Cell Biology, Columbia University, New York, NY, USA.ORCID http://orcid.org/0000-0002-4346-7343
Abdul HannanDepartments of Ophthalmology, Pathology, and Cell Biology, Columbia University, New York, NY, USA.
Sungtae YoonDepartments of Ophthalmology, Pathology, and Cell Biology, Columbia University, New York, NY, USA.ORCID http://orcid.org/0000-0001-6422-5047
Xuanyu MinDepartments of Ophthalmology, Pathology, and Cell Biology, Columbia University, New York, NY, USA.
John PeregrinDepartments of Ophthalmology, Pathology, and Cell Biology, Columbia University, New York, NY, USA.ORCID http://orcid.org/0000-0001-6174-7026
Xiuxia QuWuxi School of Medicine, Jiangnan University, Wuxi, China.ORCID http://orcid.org/0000-0002-9496-4809
Hongge LiDepartments of Ophthalmology, Pathology, and Cell Biology, Columbia University, New York, NY, USA.
Honglian YuDepartments of Ophthalmology, Pathology, and Cell Biology, Columbia University, New York, NY, USA.
Jean ZhaoDepartment of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, USA.ORCID http://orcid.org/0000-0002-4561-5688
Xin ZhangDepartments of Ophthalmology, Pathology, and Cell Biology, Columbia University, New York, NY, USA. xz2369@columbia.edu.ORCID http://orcid.org/0000-0001-5555-0825
Columbia University · USDana-Farber Cancer Institute · USJiangnan University · CNJining Medical University · CN

Funding

Tissue and Pathology CoreP50CA168504 · NCI · DANA-FARBER CANCER INST · PI Nabihah Tayob · 2013 to 2026
$30.1M
Instrumentation, Fabrication, and Design CoreP30EY019007 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Xin Zhang · 2010 to 2026
$12.9M
Regulation of FGF signaling in lacrimal gland developmentR01EY018868 · NEI · INDIANA UNIVERSITY INDIANAPOLIS · PI Xin Zhang · 2009 to 2026
$6.3M
Mechanism of Csk signaling in lacrimal gland morphogenesisR01EY031210 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ZHANG, XIN · 2020 to 2023
$1.6M
Signaling networks and transcriptional programs in lens vesicle formationR00EY032171 · NEI · WASHINGTON UNIVERSITY · PI Qian Wang · 2025 to 2026
$498k
Signaling networks and transcriptional programs in lens vesicle formationK99EY032171 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI WANG, QIAN · 2022 to 2023
$237k
NCI NIH HHS P50 CA168504NEI NIH HHS K99 EY032171NEI NIH HHS P30 EY019007NEI NIH HHS R00 EY032171NEI NIH HHS R01 EY018868NEI NIH HHS R01 EY031210
6 · The paper itself

Abstract

The patterning of epithelial buds is determined by the underlying signaling network. Here, we study the cross-talk between phosphoinositide 3-kinase (PI3K) and Ras signaling during lacrimal gland budding morphogenesis. Our results show that PI3K is activated by both the p85-mediated insulin-like growth factor (IGF) and Ras-mediated fibroblast growth factor (FGF) signaling. On the other hand, PI3K also promotes extracellular signal-regulated kinase (ERK) signaling via a direct interaction with Ras. Both PI3K and ERK are upstream regulators of mammalian target of rapamycin (mTOR), and, together, they prevent expansion of epidermal growth factor (EGF) receptor expression from the lacrimal gland stalk to the bud region. We further show that this suppression of EGF signaling is necessary for induction of lacrimal gland buds. These results reveal that the interplay between PI3K, mitogen-activated protein kinase, and mTOR mediates the cross-talk among FGF, IGF, and EGF signaling in support of lacrimal gland development.

Identifiers

PMID34193412
PMCPMC8245041
OpenAlexW3175436186

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.